BIO-TECHNE Corp (NASDAQ:TECH) – Investment analysts at Leerink Swann upped their Q3 2018 EPS estimates for BIO-TECHNE in a research note issued on Monday, according to Zacks Investment Research. Leerink Swann analyst P. Souda now forecasts that the biotechnology company will post …
0 Comments